JPWO2020261231A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020261231A5 JPWO2020261231A5 JP2021576820A JP2021576820A JPWO2020261231A5 JP WO2020261231 A5 JPWO2020261231 A5 JP WO2020261231A5 JP 2021576820 A JP2021576820 A JP 2021576820A JP 2021576820 A JP2021576820 A JP 2021576820A JP WO2020261231 A5 JPWO2020261231 A5 JP WO2020261231A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- immune cell
- cell
- receptor
- domain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962867503P | 2019-06-27 | 2019-06-27 | |
| US62/867,503 | 2019-06-27 | ||
| KRPCT/KR2019/010244 | 2019-08-12 | ||
| PCT/KR2019/010244 WO2020032784A1 (fr) | 2018-08-10 | 2019-08-12 | Liaison du récepteur antigénique chimérique à hla-dr, et cellule car-t |
| US16/715,462 | 2019-12-16 | ||
| US16/715,462 US11013765B2 (en) | 2018-08-10 | 2019-12-16 | Chimeric antigen receptor that binds HLA-DR and CAR-T cell |
| US202062991493P | 2020-03-18 | 2020-03-18 | |
| US62/991,493 | 2020-03-18 | ||
| US202063004827P | 2020-04-03 | 2020-04-03 | |
| US63/004,827 | 2020-04-03 | ||
| US202063043237P | 2020-06-24 | 2020-06-24 | |
| US63/043,237 | 2020-06-24 | ||
| PCT/IB2020/056097 WO2020261231A1 (fr) | 2019-06-27 | 2020-06-26 | Récepteur antigènique chimèrique ayant un domaine de costimulation 4-1bb |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022538425A JP2022538425A (ja) | 2022-09-02 |
| JPWO2020261231A5 true JPWO2020261231A5 (fr) | 2023-06-15 |
Family
ID=74061779
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021576820A Pending JP2022538425A (ja) | 2019-06-27 | 2020-06-26 | ４－１ｂｂ共刺激性ドメインを有するキメラ抗原受容体 |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP3990626A4 (fr) |
| JP (1) | JP2022538425A (fr) |
| KR (1) | KR20220030248A (fr) |
| CN (1) | CN114080452A (fr) |
| AU (1) | AU2020307673A1 (fr) |
| BR (1) | BR112021026406A2 (fr) |
| CA (1) | CA3144875A1 (fr) |
| MX (1) | MX2021015967A (fr) |
| WO (1) | WO2020261231A1 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114007642A (zh) | 2019-04-30 | 2022-02-01 | 森迪生物科学公司 | 嵌合受体及其使用方法 |
| KR102671410B1 (ko) * | 2021-03-03 | 2024-06-04 | 진화섭 | RANK 리간드(RANK ligand)에 특이적으로 결합하는 키메릭 항원 수용체 및 이의 용도 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050113564A1 (en) * | 2003-11-05 | 2005-05-26 | St. Jude Children's Research Hospital | Chimeric receptors with 4-1BB stimulatory signaling domain |
| JP4331227B2 (ja) * | 2004-07-09 | 2009-09-16 | 中外製薬株式会社 | 抗グリピカン３抗体 |
| AU2013204922B2 (en) * | 2012-12-20 | 2015-05-14 | Celgene Corporation | Chimeric antigen receptors |
| US20160280798A1 (en) * | 2013-11-06 | 2016-09-29 | The United States Of America, As Represented By The Secretary Department Of Health & Human Service | Alk antibodies, conjugates, and chimeric antigen receptors, and their use |
| CN106536564B (zh) * | 2014-06-02 | 2021-08-31 | 美国卫生和人力服务部 | 靶向cd-19的嵌合抗原受体 |
| US10195272B2 (en) * | 2015-03-02 | 2019-02-05 | The Nemours Foundation | Adoptive t-cell therapy using FcεRI-based chimeric antigen receptors for treating IgE-mediated allergic diseases |
| AU2016270474A1 (en) * | 2015-06-04 | 2018-01-04 | University Of Southern California | Lym-1 and Lym-2 targeted CAR cell immunotherapy |
| CN108779162B (zh) * | 2015-10-09 | 2021-12-07 | 美天施生物科技有限公司 | 嵌合抗原受体和使用方法 |
| CN106279438B (zh) * | 2016-08-24 | 2019-10-22 | 北京领柯生物科技有限公司 | 新型嵌合抗原受体及其用途 |
| US11286306B2 (en) * | 2016-12-09 | 2022-03-29 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | TLR9-binding chimeric antigen receptors |
| JP2020508080A (ja) * | 2017-02-21 | 2020-03-19 | ユーティレックス カンパニー リミテッド | Ｈｌａ−ｄｒ ｃａｒ−ｔ組成物ならびにその作製方法および使用方法 |
| US20200061114A1 (en) * | 2017-02-22 | 2020-02-27 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Il13ra2-binding chimeric antigen receptors |
| WO2018236909A1 (fr) * | 2017-06-20 | 2018-12-27 | La Jolla Institute For Allergy And Immunology | Récepteurs de lymphocytes t modifiés et leurs procédés d'utilisation dans la modulation de réponses inflammatoires et le traitement de l'athérosclérose |
| EP3661964A1 (fr) * | 2017-07-31 | 2020-06-10 | Lentigen Technology, Inc. | Compositions et méthodes de traitement du cancer par immunothérapie anti-cd19/cd20 |
| CN108715859B (zh) * | 2018-05-31 | 2021-08-03 | 中国医学科学院血液病医院(中国医学科学院血液学研究所) | 靶向cd22的嵌合抗原受体及其应用 |
-
2020
- 2020-06-26 WO PCT/IB2020/056097 patent/WO2020261231A1/fr unknown
- 2020-06-26 JP JP2021576820A patent/JP2022538425A/ja active Pending
- 2020-06-26 EP EP20831651.3A patent/EP3990626A4/fr active Pending
- 2020-06-26 BR BR112021026406A patent/BR112021026406A2/pt unknown
- 2020-06-26 AU AU2020307673A patent/AU2020307673A1/en active Pending
- 2020-06-26 MX MX2021015967A patent/MX2021015967A/es unknown
- 2020-06-26 CN CN202080047355.XA patent/CN114080452A/zh active Pending
- 2020-06-26 CA CA3144875A patent/CA3144875A1/fr active Pending
- 2020-06-26 KR KR1020227001944A patent/KR20220030248A/ko active Search and Examination
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021000103A5 (fr) | ||
| US11564945B2 (en) | Chimeric antigen receptor and use thereof | |
| US11932698B2 (en) | Anti-mesothelin chimeric antigen receptor (CAR) constructs and uses thereof | |
| US20220296690A1 (en) | Engineered t cells and uses therefor | |
| JP2019516352A5 (fr) | ||
| HRP20221348T1 (hr) | Kimerni receptori i postupci njihove uporabe | |
| EP2884999B1 (fr) | Procédé et compositions pour l'immunothérapie cellulaire | |
| JP2020506700A5 (fr) | ||
| JP2017522879A5 (fr) | ||
| RU2017105160A (ru) | Лечение рака с помощью химерного антигенного рецептора к cd33 | |
| JP2020513839A5 (fr) | ||
| JP2017524367A5 (fr) | ||
| JP2018527014A5 (fr) | ||
| RU2019128921A (ru) | Антитело к il-13ra2 и его применение | |
| JPWO2019200007A5 (fr) | ||
| JPWO2020180591A5 (fr) | ||
| WO2021176373A1 (fr) | LYMPHOCYTES T Ꝩδ ET UTILISATIONS CORRESPONDANTES | |
| CN114555791A (zh) | Il-1超家族时空限制性活性细胞因子铠装的免疫应答细胞 | |
| JPWO2020261231A5 (fr) | ||
| RU2022101671A (ru) | Химерный антигенный рецептор с костимулирующим доменом 4-1bb | |
| JPWO2021173985A5 (fr) | ||
| EP4021485A1 (fr) | Agents thérapeutiques car parallèles ciblant des cellules b (pcar) | |
| WO2021127212A2 (fr) | Systèmes et procédés de fabrication de lymphocytes t régulateurs efficaces | |
| JPWO2020018695A5 (fr) | ||
| JPWO2021186397A5 (fr) |